{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:44:44Z","timestamp":1772192684120,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.peptides.2010.10.019","type":"journal-article","created":{"date-parts":[[2010,10,26]],"date-time":"2010-10-26T08:45:23Z","timestamp":1288082723000},"page":"408-414","source":"Crossref","is-referenced-by-count":9,"title":["The latest developments in synthetic peptides with immunoregulatory activities"],"prefix":"10.1016","volume":"32","author":[{"given":"Chun-lei","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2010.10.019_bib0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1747-0285.2006.00407.x","article-title":"Characterization of binding properties of ICAM-1 peptides to LFA-1: inhibitors of T-cell adhesion","volume":"68","author":"Anderson","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.peptides.2010.10.019_bib0010","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1172\/JCI22513","article-title":"TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss","volume":"116","author":"Aoki","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.peptides.2010.10.019_bib0015","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1126\/science.285.5436.2129","article-title":"Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A","volume":"285","author":"Aramburu","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.peptides.2010.10.019_bib0020","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cellsig.2005.11.006","article-title":"Functional characterization of the calcipressin 1 motif that suppresses calcineurin-mediated NFAT-dependent cytokine gene expression in human T cells","volume":"18","author":"Aubareda","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.peptides.2010.10.019_bib0025","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.4049\/jimmunol.179.11.7605","article-title":"Peptide-mediated disruption of NFkappaB\/NRF interaction inhibits IL-8 gene activation by IL-1 or Helicobacter pylori","volume":"179","author":"Bartels","year":"2007","journal-title":"J Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.peptides.2010.10.019_bib0030","doi-asserted-by":"crossref","first-page":"ii19","DOI":"10.1136\/ard.61.suppl_2.ii19","article-title":"Orally administered RDP58 reduces the severity of dextran sodium sulphate induced colitis","volume":"61","author":"Boismenu","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.peptides.2010.10.019_bib0035","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/00365520310002922","article-title":"RDP58, a novel immunomodulatory peptide with anti-inflammatory effects A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease","volume":"38","author":"Bourreille","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0040","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.4049\/jimmunol.160.5.2215","article-title":"Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class II sequence: functional similarities but mechanistic differences with the immunosuppressive drug rapamycin","volume":"160","author":"Boytim","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10753-009-9112-8","article-title":"A synthetic peptide derived from A1 module in CRD4 of human TNF receptor-1 inhibits binding and proinflammatory effect of human TNF-alpha","volume":"32","author":"Cao","year":"2009","journal-title":"Inflammation"},{"key":"10.1016\/j.peptides.2010.10.019_bib0050","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood-2002-09-2960","article-title":"Inhibition of NF-kappaB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis","volume":"102","author":"Choi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.peptides.2010.10.019_bib0055","first-page":"477","article-title":"Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses","volume":"25","author":"Clayberger","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.peptides.2010.10.019_bib0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ni1561","article-title":"T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20","volume":"9","author":"Coornaert","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0065","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/BF03401995","article-title":"RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats: analysis of its mechanism of action","volume":"5","author":"Cuturi","year":"1999","journal-title":"Mol Med"},{"key":"10.1016\/j.peptides.2010.10.019_bib0070","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1096\/fj.06-7246com","article-title":"Renaming the DSCR1\/Adapt78 gene family as RCAN: regulators of calcineurin","volume":"21","author":"Davies","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.peptides.2010.10.019_bib0075","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.0022-202X.2005.23831.x","article-title":"Topical application of a novel immunomodulatory peptide RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model","volume":"125","author":"De Vry","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00109-008-0416-1","article-title":"Inhibition of CD40\u2013CD154 costimulatory pathway by a cyclic peptide targeting CD154","volume":"87","author":"Deambrosis","year":"2009","journal-title":"J Mol Med"},{"key":"10.1016\/j.peptides.2010.10.019_bib0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2004.03.020","article-title":"RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis","volume":"152","author":"DeVry","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0090","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.4049\/jimmunol.171.10.5064","article-title":"DQ 65-79, a peptide derived from HLA class II, mimics p21 to block T cell proliferation","volume":"171","author":"Dong","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cyto.2007.06.004","article-title":"Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library","volume":"39","author":"Dotor","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.peptides.2010.10.019_bib0100","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.4049\/jimmunol.0902056","article-title":"CD80 blockade enhance glucocorticoid-induced leucine zipper expression and suppress experimental autoimmune encephalomyelitis","volume":"183","author":"Dudhgaonkar","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0105","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.4049\/jimmunol.0803313","article-title":"A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains","volume":"182","author":"D\u00fcwel","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0110","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ibd.20344","article-title":"Suppression of colon inflammation by CD80 blockade: evaluation in two murine models of inflammatory bowel disease","volume":"14","author":"Eri","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.peptides.2010.10.019_bib0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4049\/jimmunol.181.1.126","article-title":"In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1","volume":"181","author":"Gil-Guerrero","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0120","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nbt0898-748","article-title":"Computer-assisted rational design of immunosuppressive compounds","volume":"16","author":"Grassy","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0125","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/sj.emboj.7600212","article-title":"Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125","volume":"23","author":"Heo","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.peptides.2010.10.019_bib0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2008.00676.x","article-title":"Structural modifications of ICAM-1 cyclic peptides to improve the activity to inhibit heterotypic adhesion of T cells","volume":"72","author":"Iskandarsyah","year":"2008","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.peptides.2010.10.019_bib0135","doi-asserted-by":"crossref","first-page":"17051","DOI":"10.1074\/jbc.M909219199","article-title":"Inhibition of tumor necrosis factor mRNA translation by a rationally designed immunomodulatory peptide","volume":"275","author":"Iyer","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2010.10.019_bib0140","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2174\/1381612023393170","article-title":"Rational design and development of RDP58","volume":"8","author":"Iyer","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.peptides.2010.10.019_bib0145","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1074\/jbc.273.5.2692","article-title":"Characterization and biological significance of immunosuppressive peptide D2702.75-84(E --> V) binding protein Isolation of heme oxygenase-1","volume":"273","author":"Iyer","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2010.10.019_bib0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF02850127","article-title":"(Interleukin-1 receptor antagonist) has positive effects on function and quality of life in patients with rheumatoid arthritis","volume":"23","author":"Kavanaugh","year":"2006","journal-title":"Adv Ther"},{"key":"10.1016\/j.peptides.2010.10.019_bib0155","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1747-0285.2006.00360.x","article-title":"A cell-permeable NFAT inhibitor peptide prevents pressure-overload cardiac hypertrophy","volume":"67","author":"Kuriyama","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.peptides.2010.10.019_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1016-8478(23)17383-3","article-title":"Regulation of NFAT activation: a potential therapeutic target for immunosuppression","volume":"22","author":"Lee","year":"2006","journal-title":"Mol Cells"},{"key":"10.1016\/j.peptides.2010.10.019_bib0165","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.molcel.2009.03.005","article-title":"It takes two binding sites for calcineurin and NFAT to tango","volume":"33","author":"Liu","year":"2009","journal-title":"Mol Cell"},{"key":"10.1016\/j.peptides.2010.10.019_bib0170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaut.2007.10.005","article-title":"RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model","volume":"30","author":"Liu","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.peptides.2010.10.019_bib0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3748\/wjg.15.561","article-title":"Cell-permeable Tat-NBD peptide attenuates rat pancreatitis and acinus cell inflammation response","volume":"15","author":"Long","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-60327-530-9_11","article-title":"Inhibiting proinflammatory NF-kappaB signaling using cell-penetrating NEMO binding domain peptides","volume":"512","author":"Madge","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0185","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1681\/ASN.V1091997","article-title":"In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptide","volume":"10","author":"Magee","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0190","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbrc.2010.08.091","article-title":"Cleavage by MALT1 induces cytosolic release of A20","volume":"400","author":"Malinverni","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.peptides.2010.10.019_bib0195","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1074\/jbc.M513885200","article-title":"Blockade of NFAT activation by the second calcineurin binding site","volume":"281","author":"Mart\u00ednez-Mart\u00ednez","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2010.10.019_bib0200","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrd2109","article-title":"Signalling platforms that modulate the inflammatory response: new targets for drug development","volume":"5","author":"McCulloch","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.peptides.2010.10.019_bib0205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cyto.2005.12.001","article-title":"Interleukin-1: a key inflammatory mediator in psoriasis?","volume":"33","author":"Mee","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.peptides.2010.10.019_bib0210","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.4049\/jimmunol.181.10.7300","article-title":"The effect of the JNK inhibitor JIP peptide, on human T lymphocyte proliferation and cytokine production","volume":"181","author":"Melino","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0215","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1074\/jbc.M805889200","article-title":"Inhibiting the calcineurin-NFAT (nuclear factor of activated T cells) signaling pathway with a regulator of calcineurin-derived peptide without affecting general calcineurin phosphatase activity","volume":"284","author":"Mulero","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2010.10.019_bib0220","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bbamcr.2006.12.007","article-title":"RCAN3 a novel calcineurin inhibitor that down-regulates NFAT-dependent cytokine gene expression","volume":"1773","author":"Mulero","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.peptides.2010.10.019_bib0225","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.4049\/jimmunol.152.8.3786","article-title":"Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A","volume":"152","author":"Nisco","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0230","first-page":"184","article-title":"Inhibition of cutaneous UV light-induced tumor necrosis factor-alpha protein production by Allotrap 1258, a novel immunomodulatory peptide","volume":"73","author":"Oberyszyn","year":"2001","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0235","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1091\/mbc.E06-08-0744","article-title":"RKIKK motif in the intracellular domain is critical for spatial and dynamic organization of ICAM-1: functional implication for the leukocyte adhesion and transmigration","volume":"18","author":"Oh","year":"2007","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.peptides.2010.10.019_bib0240","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.drudis.2006.06.002","article-title":"Modulating TNF-alpha signaling with natural products","volume":"11","author":"Paul","year":"2006","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.peptides.2010.10.019_bib0245","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.4049\/jimmunol.180.10.6977","article-title":"Development of a novel noncompetitive antagonist of IL-1 receptor","volume":"180","author":"Quiniou","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0250","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ni1568","article-title":"The proteolytic activity of the paracaspase MALT1 is key in T cell activation","volume":"9","author":"Rebeaud","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0255","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.molcel.2009.01.030","article-title":"A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants","volume":"33","author":"Rodr\u00edguez","year":"2009","journal-title":"Mol Cell"},{"key":"10.1016\/j.peptides.2010.10.019_bib0260","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/art.22495","article-title":"A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis","volume":"56","author":"Saito","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.peptides.2010.10.019_bib0265","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.0022-202X.2005.23859.x","article-title":"Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis","volume":"125","author":"Santiago","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0270","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/art.21108","article-title":"Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist","volume":"52","author":"Smeets","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.peptides.2010.10.019_bib0275","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/art.22324","article-title":"Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent","volume":"56","author":"Srinivasan","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.peptides.2010.10.019_bib0280","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1074\/jbc.M409521200","article-title":"CD80 binding polyproline helical peptide inhibits T cell activation","volume":"280","author":"Srinivasan","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2010.10.019_bib0285","doi-asserted-by":"crossref","first-page":"16809","DOI":"10.1073\/pnas.0805677105","article-title":"Identification of a new JNK inhibitor targeting the JNK-JIP interaction site","volume":"105","author":"Stebbins","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2010.10.019_bib0290","first-page":"1562","article-title":"Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival","volume":"28","author":"Su","year":"2008","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.peptides.2010.10.019_bib0295","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/bip.21192","article-title":"Solution structure of a novel T-cell adhesion inhibitor derived from the fragment of ICAM-1 receptor: cyclo(1,8)-Cys-Pro-Arg-Gly-Gly-Ser-Val-Cys","volume":"91","author":"Tejo","year":"2009","journal-title":"Biopolymers"},{"key":"10.1016\/j.peptides.2010.10.019_bib0300","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.MIB.0000172807.26748.16","article-title":"RDP58 is a novel and potentially effective oral therapy for ulcerative colitis","volume":"11","author":"Travis","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.peptides.2010.10.019_bib0305","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/00007890-199511270-00017","article-title":"A synthetic dimeric HLA class I peptide inhibits T cell activity in vitro and prolongs allogeneic heart graft survival in a mouse model","volume":"60","author":"Woo","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.peptides.2010.10.019_bib0310","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1161\/01.ATV.0000225286.30710.af","article-title":"Therapeutic potential of a synthetic peptide inhibitor of nuclear factor of activated T cells as antirestenotic agent","volume":"26","author":"Yu","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.peptides.2010.10.019_bib0315","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1527-3466.2007.00011.x","article-title":"Therapeutic potential of VIVIT, a selective peptide inhibitor of nuclear factor of activated T cells, in cardiovascular disorders","volume":"25","author":"Yu","year":"2007","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.peptides.2010.10.019_bib0320","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/01.mjt.0000178766.60234.e2","article-title":"Peptide-mediated immunosuppression","volume":"12","author":"Zang","year":"2005","journal-title":"Am J Ther"},{"key":"10.1016\/j.peptides.2010.10.019_bib0325","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.2174\/138161208785740225","article-title":"Inhibitors targeting the LFA-1\/ICAM-1 cell-adhesion interaction: design and mechanism of action","volume":"14","author":"Zimmerman","year":"2008","journal-title":"Curr Pharm Des"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978110004729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978110004729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T20:26:44Z","timestamp":1711916804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978110004729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0196978110004729"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2010.10.019","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}